Koyfin Home > Directory > Health Care > Aduro Biotech > Cash from Financing Activities

Aduro Biotech Cash from Financing Activities Chart (ADRO)

Aduro Biotech annual/quarterly Cash from Financing Activities from 2013 to 2020.
  • Aduro Biotech Cash from Financing Activities for the quarter ending June 06, 2020 was $0m a -116.28% decrease of 0m year over year
  • Aduro Biotech Cash from Financing Activities for the last 12 months ending June 06, 2020 was $0m a -275.67% decrease of -1m year over year
  • Aduro Biotech Annual Cash from Financing Activities for 2019 was $1m a 301.21% increase of 2m from 2018
  • Aduro Biotech Annual Cash from Financing Activities for 2018 was $-1m a 5,588.56% decrease of -84m from 2017
  • Aduro Biotech Annual Cash from Financing Activities for 2017 was $82m a 47.49% increase of 39m from 2016
Other Cash Flow Metrics:
  • Aduro Biotech Cash Flow from Operations for the quarter ending December 12, 2018 was $-1m a -1,784.81% increase of 20m year over year
  • Aduro Biotech Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-23m a 36.84% decrease of -8m year over year
  • Aduro Biotech Total Revenue for the quarter ending December 12, 2018 was $3m a -140.28% decrease of -4m year over year
View Chart On Koyfin

Quarterly ADRO Cash from Financing Activities Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$-3m
06/2018$1m
03/2018$1m

Annual ADRO Cash from Financing Activities Data

2019$1m
2018$-1m
2017$82m
2016$43m
2015$174m
2014$92m
2013$19m
2012$6m